Navigation Links
Apexus Announces HRSA's 340B Prime Vendor Contract Renewal

IRVING, Texas, Sept. 11, 2012 /PRNewswire/ -- The Health Resources and Services Administration (HRSA) has elected to continue its relationship with Apexus by renewing for another year the agreement making Apexus the government's prime vendor for the 340B program. HRSA chose to exercise this one year renewal following a careful audit and review of Apexus' proven ability to maintain, coordinate and advance the 340B Prime Vendor Program.

The agreement between Apexus and HRSA, effective September 10, 2009, has a term of two years, with three one-year renewal options. HRSA exercises the one-year renewal options each year after reviewing Apexus's abilities and performance against other potential vendors.

"We are pleased to continue our relationship with HRSA," said Christopher Hatwig, Vice President at Apexus. "As the government's prime vendor for the 340B program, we believe the program is an essential federal program, and we are committed to providing value to the eligible organizations we serve. Since our partnership began, in addition to regulatory discounts on covered outpatient drugs, the Program has added numerous value-added products and services."

The 340B Drug Pricing Program is a Federal program that requires drug manufacturers to provide outpatient drugs to eligible safety-net health organizations at a reduced price to ensure patient access to medications, which is a key component of successful clinical pharmacy services and providing a high-quality continuum of care. As the contractor to the 340B Prime Vendor, Apexus is responsible for negotiating pharmaceutical pricing below the 340B price as well as improving access to affordable medications by establishing a distribution network for pharmaceuticals to covered entities.

"We believe the 340B Drug Pricing Program helps improve access to affordable medications for covered entities and underserved patient groups," adds Hatwig. "Without the Program, we believe many of the nation's uninsured and under insured would not have adequate access to affordable medications. This Program helps alleviate additional financial burdens on the nation's safety net providers and American tax payers."

About Apexus
Founded in 2007, Apexus Inc., a nonprofit corporation, is the HRSA's Office of Pharmacy Affairs awarded contractor to serve as the prime vendor for the 340B Program. Based in Irving, Texas, the prime vendor's role is to secure sub-ceiling discounts on outpatient drug purchases and discounts on other pharmacy related products and services for participating public hospitals, community health centers, and other safety-net health care providers electing to join the program. For more information on Apexus, visit

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NuAire Announces New In-VitroCell Energy Saver CO2 Incubators
2. Thoratec Announces Presentations At Upcoming Investor Conferences
3. Hemp, Inc. Division Marijuana Inc. Announces Medical Grow Tour Venue In Portland, Oregon
4. MD+DI Announces Wireless Connectivity in Medical Devices EAST Conference in Boston, MA
5. Neurotech Reports Announces New Conference Dedicated to Consumer Applications of Neurotechnology
6. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
7. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
8. CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development
9. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
10. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
11. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  ARKRAY ... products, continues to provide evidence demonstrating the accuracy of ... World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease ... that both the Company,s GLUCOCARD ® 01 meter ... high accuracy requirements. The ability to accurately measure glucose ...
(Date:11/25/2015)... 25, 2015  Trovagene, Inc. (NASDAQ: TROV ), ... Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to ... Annual Piper Jaffray Healthcare Conference. th ... Palace Hotel in New York ... Mr. Schuh will be available for one-on-one meetings during ...
(Date:11/25/2015)... Ohio , Nov. 25, 2015 ... handle hazardous drug preparations (e.g. pharmacists, pharmacy technicians, ... and veterinary technicians). The chapter also covers all ... drugs (e.g., pharmacies, hospitals, other healthcare institutions, patient ... --> --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve the ... bather’s style and personality. From basic styles for the purist looking for simplicity ...
(Date:11/25/2015)... ... 2015 , ... Ministers, senior government and UN agencies, representatives ... of Excellence, and public R&D institutions, civil societies and other partners gathered today ... African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day ...
(Date:11/25/2015)... TX (PRWEB) , ... November 25, 2015 , ... For ... the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two ... services to aid in MAP International’s cause. , MAP International was founded in 1954 ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview ... the country to celebrate their sobriety and show through pictures what a positive ... after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
Breaking Medicine News(10 mins):